Workshop: New Guideline on Modified Release Products

The new European guideline defining the requirements on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1)  comes into effect on June 1st, 2015. We would like to draw your attention to a workshop planned and realized by AGAH together with the EUFEPS Network on Bioavailability and Biopharmaceutics which will be held in Bonn (June 15th to June 16th, 2015). The workshop is subdivided into two sections, one focusing on oral modified release forms and the second covers the new requirements for development of transdermal patch formulations.
Are you interested?

If yes, visit www.agah.eu.

Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on single